Sleep apnea device maker ResMed agrees to sell its software business MatrixCare to PE firm Frazier for $490M in cash; ResMed bought MatrixCare for $750M in 2018 (Puyaan Singh/Reuters)

Puyaan Singh / Reuters:
Sleep apnea device maker ResMed agrees to sell its software business MatrixCare to PE firm Frazier for $490M in cash; ResMed bought MatrixCare for $750M in 2018  —  ResMed (RMD.N) said on Tuesday it would sell its software business MatrixCare to private equity firm Frazier Healthcare Partners …

Posted from: this blog via Microsoft Power Automate.

Daily Deals